A carregar...
Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease
Despite the advent of biological products, such as anti-tumor necrosis factor-α monoclonal antibodies (infliximab and adalimumab), for treatment of moderate to severe cases of inflammatory bowel disease (IBD), most patients depend upon aminosalicylates as the conventional treatment option. In recent...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Co., Limited
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3974523/ https://ncbi.nlm.nih.gov/pubmed/24707139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i13.3564 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|